BLONDER TONGUE LABS INC - BDRL STOCK NEWS

Blonder Tongue Laboratories, Inc. announces the addition of the NXG-IP input module to their best-selling NXG Video Delivery Platform. The module now supports an input path failover for up to two Gigabit Ethernet input feeds, providing automatic failover from the primary feed to the secondary feed if a loss of data is detected. This cost-saving solution eliminates the need for an external router and is available as a field-upgradable firmware.

Blonder Tongue Laboratories (OTCQB:BDRL) has announced the integration of SRT Error Correction into its popular Aircaster AQT8 Series transmodulators, enhancing their utility for Remote IP/QAM Applications. This advancement allows for remote deployment, reducing costs associated with dedicated fiber connections and providing improved access to fringe stations. The integration aligns with Blonder Tongue's objective of offering innovative solutions to lower system costs. The SRT functionality, alongside the recently launched Clearview HDMI2 QAM IP and Clearview HD2X QAM IP, enables broadcasters to transmit programs safely over the public Internet. This product enhancement showcases their commitment to flexibility and efficiency in telecommunications.

OLD BRIDGE, NJ / ACCESSWIRE / February 23, 2023 / Blonder Tongue Laboratories, Inc. (OTCQB:BDRL) announces the passing of Senior Vice President and Chief Financial Officer, Eric S. Skolnik, who was 58 years old. Joining the company in May 2000, he became CFO in 2001 and held the Senior VP position for 20 years. His leadership and commitment significantly impacted the organization. Bob Palle, the incoming CEO, expressed profound sorrow and emphasized Eric's contributions and character. Michael Censoplano has been named Interim CFO, with further announcements pending.

About Blonder Tongue: The firm specializes in telecommunications and cable television technology.

Blonder Tongue Laboratories (OTCQB:BDRL) has announced the resignation of Chief Executive Officer Ted Grauch, effective March 18, 2023. Grauch has served in his role since January 2020 and cites personal goals as the reason for his departure. The Board has reappointed Robert J. Palle, who previously held leadership positions at the company, to replace Grauch. Palle, who is optimistic about future initiatives in manufacturing and technology, emphasized the importance of a smooth transition. Blonder Tongue is a leading provider in telecommunications and cable television technology, with over 50 years of operational history in New Jersey.

Blonder Tongue Laboratories, Inc. (OTCQB:BDRL) reported a 26.1% increase in net sales for Q3 2022, totaling $5.26 million, compared to $4.17 million in Q3 2021. However, the company faced a net loss of $(703,000) or $(0.05) per diluted share, a decline from a loss of $(201,000) or $(0.02) last year. The increase in sales was driven by higher demand for NXG and DOCSIS products. The company has a sales backlog of approximately $7.17 million but continues to face challenges from supply chain constraints and liquidity issues.

Blonder Tongue Laboratories, Inc. (OTCQB:BDRL) will announce its Q3 2022 earnings results on November 4, 2022, before market opening. A teleconference will follow at 11:00 a.m. ET to discuss the results with investors. Blonder Tongue is a leading U.S. designer and manufacturer of telecommunications technology, offering high-reliability products for video and data services. The company's operations are based in New Jersey, with a strong reputation for quality.

Blonder Tongue Laboratories (OTCQB: BDRL) has announced that its Drake PEG PLUS Advanced Video Encoder has been standardized by a North American tier-one broadband cable operator. The decision was influenced by the encoder's high reliability, superior video quality, and unique features, including ZIXI support. This standardization allows for efficient local content contribution and backhaul to a national IP video operations center without the need for private line leasing. The deployment will enhance the management and distribution of local broadcast content across the country.

Blonder Tongue Laboratories (OTCQB: BDRL) reported a net sales decrease of 2.4% to $4.234 million for Q2 2022, down from $4.338 million in Q2 2021. The company faced a net loss of $(1.154 million) or $(0.09) per diluted share, contrasting with a net income of $1.626 million or $0.11 per share from the previous year. Factors influencing results included rising raw materials costs, semiconductor supply issues, and a decrease in sales of certain product lines, although sales from DOCSIS data and encoder/transcoder products increased. A significant sales backlog of approximately $9.783 million was noted.